Abstract:Most episodes of acute heart failure (AHF) are characterized by increasing signs and symptoms of congestion, manifested by edema, pleura effusion and/or ascites. Immediately and repeatedly administered intravenous (IV) loop diuretics currently represent the mainstay of initial therapy aiming to achieve adequate diuresis/natriuresis and euvolemia. Despite these efforts, a significant proportion of patients have residual congestion at discharge, which is associated with a poor prognosis. Therefore, a standardized approach is needed. The door to diuretic time should not exceed 60 min. As a general rule, the starting IV dose is 20–40 mg furosemide equivalents in loop diuretic naïve patients or double the preexisting oral home dose to be administered via IV. Monitoring responses within the following first hours are key issues. (1) After 2 h, spot urinary sodium should be ≥50–70 mmol/L. (2) After 6 h, the urine output should be ≥100–150 mL/hour. If these target measures are not reached, the guidelines currently recommend a doubling of the original dose to a maximum of 400–600 mg furosemide per day and in patients with severely impaired kidney function up to 1000 mg per day. Continuous infusion of loop diuretics offers no benefit over intermittent boluses (DOSE trial). Emerging evidence by recent randomized trials (ADVOR, CLOROTIC) supports the concept of an early combination diuretic therapy, by adding either acetazolamide (500 mg IV once daily) or hydrochlorothiazide. Acetazolamide is particularly useful in the presence of a baseline bicarbonate level of ≥27 mmol/L and remains effective in the presence of preexisting/worsening renal dysfunction but should be used only in the first three days to prevent severe metabolic disturbances. Patients should not leave the hospital when they are still congested and/or before optimized long-term guideline-directed medical therapy has been initiated. Special attention should be paid to AHF patients during the vulnerable post-discharge period, with an early follow-up visit focusing on up-titrate treatments of recommended doses within 2 weeks (STRONG-HF).

The Congestion "Pandemic" in Acute Heart Failure Patients

Pathophysiology of Congestion in Heart Failure: A Contemporary Review

Congestion in heart failure: a contemporary look at physiology, diagnosis and treatment

Poor in-hospital congestion improvement in acute heart failure patients classified according to left ventricular ejection fraction: prognostic implications

Patient Selection and End Point Definitions for Decongestion Studies in Acute Decompensated Heart Failure: Part 1

Decongestion in acute heart failure: Is it time to change diuretic‐centred paradigm?

Decongestion in Acute Heart Failure—Time to Rethink and Standardize Current Clinical Practice?

A Multimodal Approach to Congestion Assessment

Assessment of filling pressures and fluid overload in heart failure: an updated perspective

Full decongestion in acute heart failure therapy

Biomarkers of Hemodynamic Congestion in Heart Failure

Contemporary Decongestive Strategies in Acute Heart Failure

Multi-modality assessment of congestion in acute heart failure: Associations with left ventricular ejection fraction and prognosis

Quantification and treatment of congestion in heart failure: A clinical and pathophysiological overview

Acute heart failure: current pharmacological treatment and perspectives

Differential Prognostic Impact of Clinical Congestion between Preserved versus Reduced Ejection Fraction in Patients Hospitalized for Acute Decompensated Heart Failure: Findings from the Japanese Kyoto Congestive Heart Failure Registry

Contemporary Decongestion Strategies in Patients Hospitalized for Heart Failure: A National Community-Based Cohort Study

Current animal models for the study of congestion in heart failure: an overview

The Importance of Optimal Hydration in Patients with Heart Failure—Not Always Too Much Fluid

Decongestion (instead of ultrafiltration?)

Exercise intervention in hospitalized heart failure patients, with emphasis on congestion-related complications: a review